Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

STORIES-Stories to Communicate Risk About Tobacco
Partnership Programs to Reduce Cardiovascular Disparities - Deep South Partnerships for Prevention of CVD Disparities
Status: Enrolling
Updated:  7/11/2016
Cooper Green Hospital
mi
from
Birmingham, AL
STORIES-Stories to Communicate Risk About Tobacco
Partnership Programs to Reduce Cardiovascular Disparities - Deep South Partnerships for Prevention of CVD Disparities
Status: Enrolling
Updated: 7/11/2016
Cooper Green Hospital
mi
from
Birmingham, AL
Click here to add this to my saved trials
STORIES-Stories to Communicate Risk About Tobacco
Partnership Programs to Reduce Cardiovascular Disparities - Deep South Partnerships for Prevention of CVD Disparities
Status: Enrolling
Updated:  7/11/2016
University of Alabama
mi
from
Birmingham, AL
STORIES-Stories to Communicate Risk About Tobacco
Partnership Programs to Reduce Cardiovascular Disparities - Deep South Partnerships for Prevention of CVD Disparities
Status: Enrolling
Updated: 7/11/2016
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth
Impact of LifeSkills Training on Blood Pressure in Youth
Status: Enrolling
Updated:  7/11/2016
Richmond County Board of Education Public Schools
mi
from
Augusta, GA
Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth
Impact of LifeSkills Training on Blood Pressure in Youth
Status: Enrolling
Updated: 7/11/2016
Richmond County Board of Education Public Schools
mi
from
Augusta, GA
Click here to add this to my saved trials
Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth
Impact of LifeSkills Training on Blood Pressure in Youth
Status: Enrolling
Updated:  7/11/2016
Medical College of Georgia - Georgia Prevention Institute
mi
from
Augusta, GA
Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth
Impact of LifeSkills Training on Blood Pressure in Youth
Status: Enrolling
Updated: 7/11/2016
Medical College of Georgia - Georgia Prevention Institute
mi
from
Augusta, GA
Click here to add this to my saved trials
Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth
Impact of LifeSkills Training on Blood Pressure in Youth
Status: Enrolling
Updated:  7/11/2016
Williams LifeSkills
mi
from
Durham, NC
Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth
Impact of LifeSkills Training on Blood Pressure in Youth
Status: Enrolling
Updated: 7/11/2016
Williams LifeSkills
mi
from
Durham, NC
Click here to add this to my saved trials
Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery
Improving Neurologic Outcomes in Diabetics Undergoing Cardiac Surgery
Status: Enrolling
Updated:  7/11/2016
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery
Improving Neurologic Outcomes in Diabetics Undergoing Cardiac Surgery
Status: Enrolling
Updated: 7/11/2016
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
REWARDS Premier Taxus-Liberte vs Xience V
REWARDS-Premier TLX (Registry Experience at the WAshington Hospital CenteR, DeS - Premier Taxus-Liberte vs Xience V)
Status: Enrolling
Updated:  7/13/2016
MedStar Washington Hospital Center
mi
from
Washington,
REWARDS Premier Taxus-Liberte vs Xience V
REWARDS-Premier TLX (Registry Experience at the WAshington Hospital CenteR, DeS - Premier Taxus-Liberte vs Xience V)
Status: Enrolling
Updated: 7/13/2016
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Change of Fructose to Fat in South Asians
Fructose-induced Hepatic De Novo Lipogenesis in South Asians
Status: Enrolling
Updated:  7/20/2016
The Rogosin Institute
mi
from
New York, NY
Change of Fructose to Fat in South Asians
Fructose-induced Hepatic De Novo Lipogenesis in South Asians
Status: Enrolling
Updated: 7/20/2016
The Rogosin Institute
mi
from
New York, NY
Click here to add this to my saved trials
Change of Fructose to Fat in South Asians
Fructose-induced Hepatic De Novo Lipogenesis in South Asians
Status: Enrolling
Updated:  7/20/2016
Weill Cornell Medical College Clinical and Translational Science Center (CTSC)
mi
from
New York, NY
Change of Fructose to Fat in South Asians
Fructose-induced Hepatic De Novo Lipogenesis in South Asians
Status: Enrolling
Updated: 7/20/2016
Weill Cornell Medical College Clinical and Translational Science Center (CTSC)
mi
from
New York, NY
Click here to add this to my saved trials
Vascular Assessment in Adult Survivors of Childhood Cancer
Vascular Assessment in Adult Survivors of Childhood Cancer
Status: Enrolling
Updated:  7/26/2016
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Vascular Assessment in Adult Survivors of Childhood Cancer
Vascular Assessment in Adult Survivors of Childhood Cancer
Status: Enrolling
Updated: 7/26/2016
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease
The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease
Status: Enrolling
Updated:  7/28/2016
Capital Health Regional Medical Center - Pediatrix Medical Group
mi
from
Trenton, NJ
The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease
The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease
Status: Enrolling
Updated: 7/28/2016
Capital Health Regional Medical Center - Pediatrix Medical Group
mi
from
Trenton, NJ
Click here to add this to my saved trials
HEARTS: Heart, Exercise, and Resistance Training Study
More Effective Exercise Modalities in Older Congestive Heart Failure Patients
Status: Enrolling
Updated:  7/28/2016
Staten Island University Hospital
mi
from
Staten Island, NY
HEARTS: Heart, Exercise, and Resistance Training Study
More Effective Exercise Modalities in Older Congestive Heart Failure Patients
Status: Enrolling
Updated: 7/28/2016
Staten Island University Hospital
mi
from
Staten Island, NY
Click here to add this to my saved trials
Association Between Abdominal Body Composition, Inflammation, and Risk for Cardiovascular Disease (The MESA ABD Study)
Abdominal Body Composition, Inflammation, and Cardiovascular Disease
Status: Enrolling
Updated:  7/28/2016
The University of California, San Diego
mi
from
La Jolla, CA
Association Between Abdominal Body Composition, Inflammation, and Risk for Cardiovascular Disease (The MESA ABD Study)
Abdominal Body Composition, Inflammation, and Cardiovascular Disease
Status: Enrolling
Updated: 7/28/2016
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Using Differences in Peripheral Blood Leukocyte Gene Expression to Determine Cardiovascular Disease Risk
Atherosclerosis Risk Refinement - a Multi-marker Approach Using Microarrays
Status: Enrolling
Updated:  7/28/2016
Northwestern University
mi
from
Chicago, IL
Using Differences in Peripheral Blood Leukocyte Gene Expression to Determine Cardiovascular Disease Risk
Atherosclerosis Risk Refinement - a Multi-marker Approach Using Microarrays
Status: Enrolling
Updated: 7/28/2016
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Identifying Genes That May Increase the Risk for Heart Disease in African Americans
Health Disparities and CVD: Admixture Mapping in the Jackson Heart Study
Status: Enrolling
Updated:  7/28/2016
University of Mississippi School of Medicine
mi
from
Jackson, MS
Identifying Genes That May Increase the Risk for Heart Disease in African Americans
Health Disparities and CVD: Admixture Mapping in the Jackson Heart Study
Status: Enrolling
Updated: 7/28/2016
University of Mississippi School of Medicine
mi
from
Jackson, MS
Click here to add this to my saved trials
Factors Associated With Coronary Heart Disease in African Americans in the Jackson Heart Study
Disparities in CHD in the Jackson Heart Study
Status: Enrolling
Updated:  7/28/2016
Jackson Heart Study
mi
from
Jackson, MS
Factors Associated With Coronary Heart Disease in African Americans in the Jackson Heart Study
Disparities in CHD in the Jackson Heart Study
Status: Enrolling
Updated: 7/28/2016
Jackson Heart Study
mi
from
Jackson, MS
Click here to add this to my saved trials
Comparison of Hematocrit Levels in Infant Heart Surgery
Hematocrit Strategy in Infant Heart Surgery
Status: Enrolling
Updated:  7/28/2016
Children's Hospital
mi
from
Boston, MA
Comparison of Hematocrit Levels in Infant Heart Surgery
Hematocrit Strategy in Infant Heart Surgery
Status: Enrolling
Updated: 7/28/2016
Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Effect of Exercise on Elevated C-reactive Protein Concentrations in Formerly Inactive Adults
INFLAME: Inflammation and Exercise
Status: Enrolling
Updated:  7/28/2016
Pennington Biomedical Research Center, LSU System
mi
from
Baton Rouge, LA
Effect of Exercise on Elevated C-reactive Protein Concentrations in Formerly Inactive Adults
INFLAME: Inflammation and Exercise
Status: Enrolling
Updated: 7/28/2016
Pennington Biomedical Research Center, LSU System
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
Estradiol for Neurocognitive Dysfunction After CABG
Status: Enrolling
Updated:  7/28/2016
Washington University
mi
from
St. Louis, MO
Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery
Estradiol for Neurocognitive Dysfunction After CABG
Status: Enrolling
Updated: 7/28/2016
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Phoenix, AZ
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Tucson, AZ
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Buena Park, CA
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Buena Park, CA
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Calabasas, CA
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
mi
from
Calabasas, CA
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Fresno, CA
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Santa Ana, CA
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Walnut Creek, CA
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Centennial, CO
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Centennial, CO
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Trumbull, CT
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Trumbull, CT
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Washington,
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Clearwater, FL
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Delray Beach, FL
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Delray Beach, FL
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Jacksonville, FL
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Miami, FL
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
mi
from
Ponte Verde, FL
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
mi
from
Ponte Verde, FL
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Bloomingdale, IL
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Bloomingdale, IL
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Chicago, IL
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Evansville, IN
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Baltimore, MD
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Oxon Hill, MD
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Oxon Hill, MD
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Jackson, MS
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Saint Louis, MO
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
North Platte, NE
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
North Platte, NE
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Omaha, NE
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Las Vegas, NV
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Nashua, NH
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Nashua, NH
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Toms River, NJ
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Mineola, NY
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Mineola, NY
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
New York, NY
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Calabash, NC
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
A Randomized Double Blind, Placebo-controlled Clinical Trial to Assess the Effects of Taspoglutide (RO5073031) on Cardiovascular Outcomes in Subjects With Inadequately Controlled Type 2 Diabetes and Established Cardiovascular Disease
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Calabash, NC
Click here to add this to my saved trials